Renal Cancers Withdrawn Phase 2 Trials for Siltuximab (DB09036)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00311545S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney CancerTreatment